Skip to main content
Equibles

Alexey Aleshin

Natera, Inc. (NTRA)

Equibles does not estimate personal net worth.

Get an email with a short summary when Natera, Inc. publishes a filing, an earnings call transcript or a press release.

Get NTRA alerts

About Alexey Aleshin

Alexey Aleshin has spoken on 3 earnings calls across 1 company, most recently for Natera, Inc. on November 5, 2026. Natera, Inc. is classified in the Diagnostics & Research industry within the Healthcare sector. Other leadership on record at Natera, Inc. includes Steven L. Chapman (CEO), Matthew Rabinowitz (Chairman and Board Member), Michael Brophy (CFO) and 7 others.

Alexey Aleshin on recent calls

“This quarter, we're completing the most significant upgrade to the Signatera products since launch, and I want to spend a moment on why it matters.”
Other, Natera, Inc. Q3 Earnings Conference Call ·
“Here we're highlighting what we view as exceptional momentum in bladder cancer going into the ASCO-GU conference.”
Other, Natera, Inc. Q4 FY2025 Earnings Call ·
“Colorectal cancer is both common and highly preventable when detected early, before or right as the cancer develops. Traditional screening works, but participation is uneven.”
Other, Natera, Inc. Q3 FY2025 Earnings Call ·

Affiliation history

Company network

Leadership on record at Natera, Inc.

Recent activity